Murine Models to Evaluate Novel and Conventional Therapeutic Strategies for Cancer
Top Cited Papers
- 1 March 2007
- journal article
- review article
- Published by Elsevier in The American Journal of Pathology
- Vol. 170 (3) , 793-804
- https://doi.org/10.2353/ajpath.2007.060929
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implicationsBlood, 2006
- How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and menEuropean Journal Of Cancer, 2005
- Clonogenic assay with established human tumour xenograftsEuropean Journal Of Cancer, 2004
- Integrating pharmacology and in vivo cancer models in preclinical and clinical drug developmentEuropean Journal Of Cancer, 2004
- “Of mice and men”European Journal Of Cancer, 2004
- Orthotopic models of cancer for preclinical drug evaluationEuropean Journal Of Cancer, 2004
- Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in EuropeEuropean Journal Of Cancer, 1995
- Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlationsCancer, 1984
- A Critical Appraisal of the Human Tumor Stem-Cell AssayNew England Journal of Medicine, 1983
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978